Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

Date:

Genentech Launches Direct-to-Consumer Program, Cuts Flu Vaccine Price by Nearly 70 Percent

The Genentech logo displayed at the company’s headquarters in San Francisco in a file photo. Justin Sullivan/Getty Images

Roche Group’s Genentech has joined the growing ranks of pharmaceutical companies selling prescription drugs directly to patients by making its Xofluza antiviral flu medicine available through online pharmacies.

Genentech’s Direct-to-Patient (DTP) program allows patients to order the single-dose vaccine from Alto Pharmacy, Amazon Pharmacy, and Mark Cuban’s Cost Plus Drugs, San Francisco-based Genentech said on Oct. 16. Patients can order the vaccine for $50, a 70-percent reduction from its list price, Genentech said.

spot_imgspot_imgspot_img

Share post:

More like this
Related

Brazilian President Lula Kicks Off Election Campaign

Brazilian President Luiz Inácio Lula da Silva kicks off...

Search Operations Continue After Powerful Indonesian Earthquake

Search operations continue in Maumere, Indonesia, on Aug. 16...

US Mortgage Rates Fall for First Time in 6 Weeks

The weekly average rate on a 30-year fixed-rate mortgage...

Apple to Begin Mac Mini Production in US

Apple will begin manufacturing Mac minis from its Houston...